↓ Skip to main content

Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia

Overview of attention for article published in Investigational New Drugs, May 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

twitter
1 X user
patent
4 patents

Citations

dimensions_citation
185 Dimensions

Readers on

mendeley
155 Mendeley